Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor

Inflammatory bowel diseases (IBDs) are chronic conditions of the gastrointestinal tract in which dysregulated immune responses cause persistent inflammation of the gut mucosa. Biologic therapy with anti-TNF blockers has revolutionized the therapeutic management of IBD for their remarkable efficacy a...

Full description

Bibliographic Details
Main Authors: Cristiano Pagnini, Theresa T. Pizarro, Fabio Cominelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Pharmacology
Subjects:
inflammatory bowel disease
Crohn’s disease
ulcerative colitis
therapy
biologics
oral small molecules
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00671/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00671/full

Similar Items